<DOC>
	<DOCNO>NCT00220337</DOCNO>
	<brief_summary>The purpose study determine lacosamide ( SPM 927 ) safe take longer period time whether continue work well treat pain . Subjects receive lacosamide dose individually determine one provide pain relief least side effect . The maximum dose 600mg/day . Subjects may participate trial October 2007 . This time may extend allow participate lacosamide commercially available . If subject meet requirement study Visit 1 two week phase without trial medication , s/he enters Titration Phase determine personal optimal dose lacosamide . When dose reach s/he enter Maintenance Phase ask return visit every 4 week first 24 week every 12 week thereafter .</brief_summary>
	<brief_title>A Trial Assess Long-term Safety Efficacy Lacosamide Subjects With Painful Diabetic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Pain</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<criteria>Painful diabetic neuropathy clinically relevant liver enzyme abnormality impair renal function , cardiac abnormality , pregnant nursing female</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>